After this virtual tumor board, the participants should be able to:

1. Describe the key best-practice components of ERAS pathways in CRS/HIPEC in the pre-, intra-, and postoperative periods.
2. Understand how ERAS protocols may help reduce both complications and length of stay after complex procedures
3. Give examples of ERAS protocol modifications that may be necessary at times based on patient, procedure, and tumor factors.

Moderating this session will be Scott K. Sherman, MD, University of Iowa Carver College of Medicine

Panelists:

Beth A. Helmink, MD, PhD, Washington University School of Medicine
Hatem Halabi, MD, FACS, Surgical oncology Cancer Treatment Centers of America part of City of Hope 
Kiran K. Turaga, MD, MPH, University of Chicago Medicine
Fadi S. Dahdaleh, MD, Edward-Elmhurst Health